🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Philippe Gallay

Scripps Research Institute

ORCID: 0000-0002-6151-4764
Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Structurally distinct cyclosporin and sanglifehrin analogs CRV431 and NV556 suppress established HCV infection in humanized-liver mice”.

Structurally distinct cyclosporin and sanglifehrin analogs CRV431 and NV556 suppress established HCV infection in humanized-liver mice

PLoS ONE(2020)10.1371/journal.pone.0237236
N/A
0DataRank · unranked
15 citations

Magnus J. Hansson, Patrick Mayo, Daren Ure, Robert T. Foster, Philippe Gallay +1 more

The inhibitor of apoptosis proteins antagonist Debio 1143 promotes the PD-1 blockade-mediated HIV load reduction in blood and tissues of humanized mice

PLoS ONE(2020)10.1371/journal.pone.0227715
N/A
0DataRank · unranked
4 citations

Joseph Kuo, Udayan Chatterji, Norbert Wiedemann, Grégoire Vuagniaux, Philippe Gallay +1 more

Highly synergistic drug combination prevents vaginal HIV infection in humanized mice

Scientific Reports(2020)10.1038/s41598-020-69937-5
N/A
0DataRank · unranked
4 citations

Christina M. Ramirez, John A. Moss, Manjula Gunawardana, Michael Bobardt, Philippe Gallay +1 more

Fundamental aspects of long-acting tenofovir alafenamide delivery from subdermal implants for HIV prophylaxis

Scientific Reports(2022)10.1038/s41598-022-11020-2
N/A
0DataRank · unranked
19 citations

Mariana Remedios-Chan, Debbie Sanchez, Simon G. Webster, Amalia E. Castonguay, Paul Webster +13 more

Preclinical Considerations for Long-acting Delivery of Tenofovir Alafenamide from Subdermal Implants for HIV Pre-exposure Prophylaxis

Pharmaceutical Research(2022)10.1007/s11095-022-03440-6
N/A
0DataRank · unranked
6 citations

Mariana Remedios-Chan, Debbie Sanchez, Rob Fanter, Simon G. Webster, Paul Webster +9 more

Acute antagonism in three-drug combinations for vaginal HIV prevention in humanized mice

Scientific Reports(2023)10.1038/s41598-023-31695-5
N/A
0DataRank · unranked
2 citations

Christina M. Ramirez, Marc M. Baum, Philippe Gallay

The Cyclophilin Inhibitor Rencofilstat Decreases HCV-induced Hepatocellular Carcinoma Independently of Its Antiviral Activity

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.08.19.553982
N/A
0DataRank · unranked
2 citations

Michael Bobardt, Daren Ure, Robert T. Foster, Philippe Gallay, Winston T Stauffer

Cyclophilin inhibition as a strategy for the treatment of human disease

Frontiers in Pharmacology(2024)10.3389/fphar.2024.1417945
N/A
0DataRank · unranked
24 citations

Asha Z. Goodman, Philippe Gallay, Winston T Stauffer

Cyclophilin D knockout significantly prevents HCC development in a streptozotocin-induced mouse model of diabetes-linked NASH

PLoS ONE(2024)10.1371/journal.pone.0301711
N/A
0DataRank · unranked
7 citations

Michael Bobardt, Daren Ure, Robert T. Foster, Philippe Gallay, Winston T Stauffer

Mice lacking cyclophilin B, but not cyclophilin A, are protected from the development of NASH in a diet and chemical-induced model

PLoS ONE(2024)10.1371/journal.pone.0298211
N/A
0DataRank · unranked
9 citations

Asha Z. Goodman, Michael Bobardt, Daren Ure, Robert T. Foster, Philippe Gallay +1 more